Affiliations 

  • 1 Department of Biochemistry, Faculty of Life Sciences, University of Maiduguri, Nigeria. Electronic address: yahayatijani@unimaid.edu.ng
  • 2 Department of Biochemistry, Faculty of Life Sciences, University of Maiduguri, Nigeria
  • 3 Venom Research and Toxicology Laboratory, Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: tanch@um.edu.my
  • 4 Department of Microbiology, Faculty of Life Sciences, University of Maiduguri, Nigeria. Electronic address: abshettima@unimaid.edu.ng
  • 5 Department of Biochemistry, Faculty of Chemical and Life Science, Usman Danfodiyo University Sokoto, Nigeria
  • 6 Department of Bacteria and Vaccine Production, National Veterinary Research Institute, Plateau State, Nigeria
  • 7 Department of Infectious and Trans-boundary Animal Diseases, National Veterinary Research Institute, Plateau State, Nigeria
  • 8 Department of Veterinary Microbiology, Faculty of Veterinary Medicine, Usman Danfodiyo University, Sokoto, Nigeria
  • 9 College of Health Sciences, Bayero University Kano, Nigeria
Toxicon, 2024 Jul 01;248:107845.
PMID: 38960288 DOI: 10.1016/j.toxicon.2024.107845

Abstract

Echis ocellatus is one of the commonest snakes responsible for envenomation in Nigeria. Antivenom is the only effective treatment, but the country suffers from a limited supply of effective antivenom. This study therefore aimed to explore the feasibility of effective, mono-specific antibodies production through immunization in rabbits using the venom of Echis ocellatus from Nigeria. The World Health Organization guide on antivenom production was employed in the immunization and the resultant antibodies were purified using protein A agarose column chromatography. Antibody titer reached a high plateau by 2-month immunization, and SDS PAGE of the sera suggests the presence of intact immunoglobulins accompanied with the heavy (50 kDa) and light (25 kDa) chains. The venom has an intravenous LD50 of 0.35 mg/kg in mice, and the venom lethality at a challenge dose of 2 LD50 was effectively neutralized by the antibodies with a potency value of 0.83 mg venom per g antibodies. The antibodies also neutralized the procoagulant activity of the venom with an effective dose (ED) of 13 ± 0.66 μl, supporting its use for hemotoxic envenomation. The study establishes the feasibility of developing effective, mono-specific antibodies against the Nigerian Carpet viper.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.